A Phase I Study of an Anti-IDO1 Inhibitor (LY3381916) as Monotherapy and in Combination with an Anti-PD-L1 Antibody (LY3300054) in Patients with Advanced Cancer von Kotecki, N., O'Neil, B., Jalal, S., Massard, C., Wallin, J., Szpurka, A., Wang, D., Galvao, V. Regnier, Xia, M.S., Crowe, K., Geeganage, S., Doman, T., Gandhi, L., Xu, X., Bendell, J.

Volltext

Erythema multiforme induced by clindamycin diagnosed by patch test von Saliba, Bruna Gama, Simis, Nathalia Pessoa, Ribeiro, Marisa Rosimeire, Garro, Laila Sabino, Portilho, Nathália Coelho, Kalil, Jorge, Giavina-Bianchi, Pedro, Motta, Antonio Abílio, Aun, Marcelo Vivolo, Galvão, Violeta Regnier

Volltext